Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence
Review Article on Pollutional Haze

Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence

Yixing Du1,2*, Xiaohan Xu3*, Ming Chu1,, Yan Guo1, Junhong Wang1

1Department of Gerontology, 2Department of Neurology, 3Department of Thoracic Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Contributions: (I) Conception and design: J Wang; (II) Administrative support: Y Guo; (III) Provision of study materials or patients: J Wang, Y Du; (IV) Collection and assembly of data: M Chu, X Xu; (V) Data analysis and interpretation: Y Du, X Xu, J Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

*These authors contributed equally to this work.

Correspondence to: Dr. Junhong Wang. Department of Gerontology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. Email: cnjjh2000@aliyun.com.

Abstract: Air pollution is now becoming an independent risk factor for cardiovascular morbidity and mortality. Numerous epidemiological, biomedical and clinical studies indicate that ambient particulate matter (PM) in air pollution is strongly associated with increased cardiovascular disease such as myocardial infarction (MI), cardiac arrhythmias, ischemic stroke, vascular dysfunction, hypertension and atherosclerosis. The molecular mechanisms for PM-caused cardiovascular disease include directly toxicity to cardiovascular system or indirectly injury by inducing systemic inflammation and oxidative stress in peripheral circulation. Here, we review the linking between PM exposure and the occurrence of cardiovascular disease and discussed the possible underlying mechanisms for the observed PM induced increases in cardiovascular morbidity and mortality.

Keywords: Particulate matter (PM); cardiovascular disease; morbidity; mortality


Submitted Jun 19, 2014. Accepted for publication Oct 28, 2015.

doi: 10.3978/j.issn.2072-1439.2015.11.37


Introduction

Air pollution has now emerged as a leading problem for environmental health in the world. Especially in developing countries, it has become more serious than ever before. The potentially detrimental to health of air pollution has long been recognized, and many large epidemiological studies have clearly demonstrated the strong association between air pollution exposure and increased morbidity and mortality (1-3). Air pollutants include gaseous pollutants (e.g., carbon mono oxide, oxides of nitrogen, ozone and sulfur dioxide) and particulate matters (PMs). The relationship between respiratory vulnerability and air pollution has been well documented, and much attention has now been focused on the air pollution-induced cardiovascular risk in the past 15 years (4-6). Of those air pollutants, the ambient PM has become a major concern for cardiologists and specialists in environmental medicine. There is a mounting epidemiological, biomedical and clinical evidence that indicates the effects of ambient PM on cardiovascular health (5,7,8). In this review we summarize the main findings on the impact of PM particles on cardiovascular system and discuss the underlying molecular mechanisms of the effects of PM particles on cardiac muscle and vasculature.


The definition and composition of ambient particulate matter (PM)

Ambient PM is defined as the material suspended in the air in the form of minute solid particles or liquid droplets, which are derived from both human and natural activities. It is a heterogeneous mixture with varying size and chemical composition. In terms of their potential influence on health, they are classified as PM10, PM2.5 and ultrafine particles (UFPs) subgroup according to their diameter. PM10 includes coarse particles with the aerodynamic diameter (AD) from 2.5 to 10 μm. The PM10 particles come from road and agricultural dust, tire wear emission, construction and demolition works or the mining operations (8). In addition, the natural activity such as wildfires and windblown dust are also the sources for PM10. Compared to PM10, the primary contributors of PM2.5 mainly come from the traffic and industry includes fuel combustion from power plant and oil refinery or the brake emissions of mobile. PM2.5 indicates those fine particles with AD less than 2.5 μm. Based on numerous epidemiological studies and large clinical observation, the PM2.5 has been considered as the main culprit of the adverse cardiovascular effects of air pollution on human health (5,6). UFPs include those particles diameters less than 0.1 μm, and the primary sources of UFPs are tailpipe emissions from mobile sources. Theoretically, PM10 particles preferentially deposit in the upper airways, meanwhile the PM2.5 and UFPs particles are much more easier to reach the smallest airways and alveoli and UFPs may further penetrate the alveolar-capillary membrane, which eventually spread into the systemic circulation. It has been reported that the UFPs particles can be found in remote organs (9). This finding may indicate that UFPs could induce specific organ toxic effects. In addition, the secondary particular matters, ambient aerosols appear when ambient particles interact with atmospheric gases (ozone, sulfur and nitric oxides and carbon monoxide) (8). Each of those aerosols can have independent and potentially synergistic or antagonistic effects with each other and with PM; however, at present, the cardiovascular health impact of exposure to combinations of those air pollutants is not well understood (5).


Pathophysiological mechanisms linking particulate matter (PM) particles and cardiovascular disease

In the past 15 years, numerous studies and in-depth reviews have demonstrated that PM particles play a significant role in the process of cardiovascular disease. Table 1 summarizes the most recent studies [2014-2015] on PM-induced short-term and long-term cardiovascular effects. There is a strong link between the PM particles and the deaths caused due to cardiovascular diseases (4,21,28,31-33), and several pathways have recognized that can explain the link between PM particles and cardiovascular diseases, the first is the direct pathway. In this way, PM2.5, in particular UFPs directly translocate into the blood stream and remote target organ, and the other two pathways are indirect. For the indirect pathways, the one is mediated by pulmonary oxidative stress and inflammatory response, which is less acute and occur after several hours or days of inhalation (6,34). Interaction on the autonomic nervous system via specific lung receptors is an another indirect pathway well documented by many authors (6,8).

Table 1
Table 1 The representative recent studies [2014-2015] on the short-term and long-term effects of exposure to PMs on cardiovascular system
Full table

Direct actions of ultrafine particles (UFPs) on cardiovascular system

Due to the size, charge, chemical composition of UFPs, it is much easier to cross the pulmonary epithelium and the lung-blood barrier than PM10 and other coarse particulate. Thus, the translocation of UFPs into the blood stream and specific organ has been documented in animal studies (35-39). This exposure, even at low concentration, can translocate into blood steam and remote organ to cause potential cumulative toxicity (39). The translocation of UFPs to the blood stream has detrimental effects on cardiovascular system. After deposit on vascular endothelium, the UFPs can aggravate the local oxidative stress and inflammation, resulting the atherosclerotic plaque instability, and finally may lead to thrombus formation (40). Furthermore, increased ejection fraction and premature ventricular beats was observed in rats intravenously injected with UFPs isolated from ambient air (41). This inotropic effect of UFPs may be harmful to coronary heart disease patients, which increase the oxygen demand of the diseased hearts and aggravate the ischemic symptom. However, the in vitro results of UFPs on cardiac performance demonstrated that the UFPs have the cardiac depression effects, which can cause myocardial stunning and cardiac function deterioration (42). The seemed contradictable in vivo and in vitro results might be explained as the difference in circulation-mediated or direct cardiotoxicity of UFPs in these two models (8). Although not observed in human beings so far, these studies still indicated that UFPs has the cardiotoxicity effects and can directly affect the cardiac performance.

Indirect pathways of particulate matter (PM) particulates on cardiovascular system

Increased oxidative stress and activated inflammatory pathway in pulmonary due to exposure to PM particulate play a substantial role in this indirect pathway. Considerable evidence has proved that particulate air pollutants can trigger an inflammation related cascade when they deposit in the lung (43-46). Increased circulating level of pro-inflammatory cytokines such as CRP, IL-6, IL-8 and IL-1β were observed in healthy subjects when exposure to ambient PMs (46-50). Similar results have been reported in in vivo animal models and in vitro cellular models (51,52). Systemic inflammatory is a well-known risk factor for atherosclerosis progression, and those pro-inflammatory mediators are close related to increased blood coagulability and endothelial dysfunction and which finally can exacerbate myocardial ischemia. In addition, ROS-dependent mechanism was shown to involved in the PM particulates triggered pro-inflammatory pathway (47). Increased amounts of ROS were reported in rat lung and heart by means of in situ chemiluminescence after exposure to PMs (47). ROS was shown to be linked to atherosclerosis, vascular dysfunction, cardiac arrhythmias and myocardial injury (53,54).

Other mechanisms for particulate matter (PM)-induced cardiovascular disorders

In addition to the sizes of PMs, the quality of PMs (components) also played an important role in PM-related harmful effects. The components of PMs varies spatially and temporally, which includes health hazardous metals, such as copper, lead, iron, nickel and chromium originate from industrial combustion processes or traffic combustion. Other gaseous pollutants (e.g., CO, NO2, NOX, O3 and SO2 etc.) have also been demonstrated to be close related to the adverse outcomes of cardiovascular disease (10,17,18,24,26).

Furthermore, PM particulates are thought to stimulate autonomic nervous system (55), impairing autonomic balance and favoring sympathetic tone (56). The over activated sympathetic tone is closely related to increased cardiovascular risk through induction of pro-hypertensive vasoconstriction and the predisposition to arrhythmias (56). Recently, microRNAs (miRNAs) have emerged as attractive candidates to explore the impact of PM exposures on cardiovascular system (57,58). Experimental and clinical studies indicated that PMs can modulate those miRNAs involved in processes of systemic inflammation, endothelial dysfunction and atherosclerosis. Meanwhile, SNPs in miRNA-processing genes may also modify the associations between ambient pollution and cardiovascular disease (58,59). However, further work remains need to be addressed include linking specific PM exposures to subsequent health outcomes based on established miRNA expression profiles and experimentally validating putative downstream targets of the deregulated miRNAs.


The linking between ambient particulate matters (PMs) and cardiovascular disease

Cardiovascular (CV) mortality and particulate matter (PM) particulates exposure

The positive relationship between CV mortality and PM particulates exposure has been proved in many large time-series and case-crossover studies. Even a 10 μg/m3 increase in short-term (<24 h) PM2.5 level increases the relative risk (RR) of daily cardiovascular mortality by ~0.4% to 1.0% (60). In addition, several landmark time-series studies have been conducted worldwide in recent years to address the daily PM-related CV and all-cause mortality. One of the largest was the National Morbidity, Mortality and Air Pollution Study (NMMAPS) (61,62). The APHEA (Air pollution and Health: A European Approach) and APHEA-2 projects investigated the relationship between short-term PM exposure and CV mortality in multiple European cities (63,64). Those large studies revealed that PM particulates including the coarse particulates, PM10, were significantly associated with daily all-cause and CV mortality. Similar time-series studies conducted in Asia countries (China, Thailand and Indian) further confirmed the relationship between the daily PM-exposure and CV mortality (65-67).

In addition to the short-term exposure of PM particulates, the longer-term exposure may have more deleterious effects on healthy and cardiovascular mortality giving the more accumulated PM exposure during the extended periods of time. Miller et al. revealed that long-term exposure to fine particulate air pollution was associated with the incidence of cardiovascular disease and death among postmenopausal women based on the data from 36 USA metropolitan areas (33). Many large prospective cohort studies and fine meta-analysis have further provided us with clear answers on the correlation between longer-term PM-exposure and CV mortality (29,68,69). However, a most recent large cohort study performed by Beelen et al. (29) did not found any association between PM and cardiovascular mortality. The explanation for the difference between this study and those of previous studies may be because of the changes in cardiovascular risk profile (e.g., reduced smoking and increased medication and medical treatment). And the changed risk profile finally altered the relationship between air pollution and cardiovascular mortality. The extended reanalysis of the two large cohort studies—the Harvard Six Cities and ACS Studies further emphasized the notorious effects of PM2.5 on CV mortality (2,32,70). Furthermore, studies demonstrated that significantly reduction of PM2.5 level was associated with reduced mortality risk (70,71). However, unlike the results observed in short-term exposure studies, the reanalysis of ACS study demonstrated that the coarse particles (PM10) were generally not significantly related to CV mortality (32).

Ischemic heart disease (IHD) and particulate matter (PM) particulates exposure

An earlier hospital-based study (72) demonstrated that the incidence of myocardial infarction (MI) and angina was found to associate with atmospheric gases and/or black smoke. Another studies conducted in USA (4-year in 204 counties) and European (10-year in five major cities) indicated that hospital admission for IHD were positively associated with increased level of fine PM particulates (73,74). Furthermore, a very recent large prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE project confirmed that long term exposure to PM is associated with incidence of coronary events, and this association persists at levels of exposure even below the current European limit values (25 μg/m3 for PM2.5, 40 μg/m3 for PM10) (75). They concluded that with a 5 μg/m3 increase in estimated annual mean PM2.5 was associated with a 13% increased risk of coronary events (HR 1.13, 95% confidence interval 0.98 to 1.30), and a 10 μg/m3 increase in estimated annual mean PM10 was associated with a 12% increased risk of coronary events (1.12, 1.01 to 1.25). In California teachers cohort study (76), Lipsett et al. provided evidence linking long-term exposure to PM2.5 with increased risks of incident IHD mortality, particularly among postmenopausal women. Meanwhile, exposure to nitrogen oxides was also associated with elevated risks for IHD and all cardiovascular mortality. In addition to the long-term effects of PM on IHD, short-term elevated ambient fine PM concentrations has also been reported to increase the IHD hospital admission, which was further proved by numerous time-series, case-crossover and meta-analysis studies (69,77,78). Recently a large cohort study investigated the relationship between occupational particle exposure and the incidence of IHD in Swedish workers. They found that either exposure to a small job-exposure matrix (<1 μm) or large (>1 μm) was associated with an increased HR for acute MI, and the association was somewhat stronger for those exposed to small particles for more than 5 years (79).

Although few direct evidence for the induction of cardiac ischemia by exposure to ambient level of PM has been documented in real patient world, the experimental MI model provided more evidence linking PM exposure and increased infarct size and/or potential myocardial ischemia (80-82). The mechanisms for PM exposure induced myocardial ischemic injury can be attributed to increased systemic inflammation, altered endothelial function and enhanced thrombotic tendency (80,83). In addition, the PM exposure was found to be associated with a small but significant decrease in myocardial flow, especially in ischemic area in a conscious canine myocardial ischemic model (82). Moreover, traffic-related PM in patients with coronary artery disease was found to be strongly related to the incidence of ST-segment depression during 24-hour Holter monitoring.

Cardiac arrhythmias, out-of-hospital cardiac arrest (OHCA) and particulate matter (PM) particulates exposure

Several studies have observed a positive association between exposure to ambient PM and the incidence of ventricular arrhythmias in patients implanted with automatic defibrillators (84,85). A 5-year prospective study (86) in Taipei demonstrated that increased numbers of emergency room cardiac arrhythmia visits were significantly associated with PM2.5 on both warm days (>23 °C) and cool days (<23 °C), with an interquartile range rise associated with a 10% and 4% elevation in number of ER visits for cardiac arrhythmias, respectively. Very recently, another prospective follow-up study evaluated the association of air pollution with the onset of atrial fibrillation (AF) in 176 patients with dual chamber implantable cardioverter-defibrillators (ICDs). The authors revealed that PM2.5 is an acute trigger of AF, which was associated with increased odds of AF onset [26% (95% CI: 8-47%) increase for each 6.0 mg/m3 increase in PM2.5 concentration] within hours following exposure in patients with known cardiac disease (87). Similarly, PM2.5 or fine PM-exposure has been reported to be associated with OHCA in Melbourne (88), Houston (89), New York (90), and many other cities or countries but not in Demark (91) and Seattle (92). These seemed inconsistent results may reflect different PM compositions due to different sources among the cities and countries. Furthermore, the lower exposure levels in Demark and Seattle than in New York and Houston should also be considered.

In general, the incidence of sudden cardiac death and cardiac arrhythmias is closely related to the activity of the autonomic nervous system, and its activity in susceptible patients can be evaluated by measuring the changes in heart rate variability (HRV). HRV is mediated by a balance between sympathetic and parasympathetic branches of autonomous nervous system (34), which is recognized as a marker for prognosis the incidence of ventricular arrhythmia. Reduced HRV often predict the likelihood of developing ventricular arrhythmias in post-MI and heart failure patients (93,94). The reductions in HRV were observed on exposure to ambient, household or occupational PMs in healthy volunteer, susceptible patients, housewives and workers (95-97). In the studies in Beijing, the authors demonstrated an increase in HRV in healthy volunteers and CHD patients when exposure to ambient PM particles. On the contrary, the protective effects were observed when the participants used the highly efficient facemask (98,99). Although the mechanisms for PMs induced HRV and other changes in ECG remain largely unknown, some studies demonstrated that PM-induced cardiac electrophysiological changes can be prevented by inhibiting the transient receptor potential vanilloid receptor 1 (TRPV1) in the lungs (100). In addition, there have been relatively few researchers studied on the gene-PM exposure interactions, and most have done on a small number of loci for genetic polymorphisms. Some authors indicated that the associations between PM2.5 and HRV can be modified by gene polymorphisms of apolipoprotein E (APOE), lipoprotein lipase (LPL), vascular endothelial growth factor (VEGF) and glutathione S-transferase (GST) in general population, and the biological metabolism for PM related HRV changes might be related to the action on autonomic function via the lipid/endothelial metabolism and oxidative stress pathways (101,102).

Vascular function, blood pressure (BP), atherosclerosis and particulate matter (PM) particulates exposure

Experiments demonstrated that PM particulates can cause excess ROS formation thus leading to impairment of nitric oxide-dependent vascular dilation and enhancing vasoconstrictor in ex vivo and in vivo studies (5,103). Furthermore, exposure to PM has found to be associated with an increase in plasma concentration of endothelin-1 (ET-1), which is a putative potent endogenous vasoconstrictor to cause vascular endothelial dysfunction (104,105). Although the PM-related vascular dysfunction is documented in many articles, the results for BP response to acute PM exposure is inconsistent. Some controlled studies reported that PM exposure cause no changes among healthy adults, while other recent findings suggested that actual period of exposure to concentrated ambient particulate (CAP) significantly increase the diastolic BP (106), whereas no changes was observed with longer time of exposure (24 h) to PM (107). In that, those results suggested that this CAP induced BP changes might be more related to the PM-induced ANS imbalance which favored sympathetic over parasympathetic cardiovascular tone.

Although a recent meta-analysis from four European cohort studies in the ESCAPE study only find a positive but not significant associations between CIMT and long-term exposure to the PM2.5 (108), many epidemiological and animal evidences still documented that exposure to PMs plays a role in the development of atherosclerosis. Sun and his colleague demonstrated that exposure to environmentally relevant PM2.5 (regional northeastern of US) in conjunction with a high-fat chow diet in ApoE−/− mice for 6 months can cause endothelial dysfunction, increase the vascular plaque burden and accelerate the progression of atherosclerosis (109). The same results were reported in Beijing, Los Angeles and many other places when the ApoE−/− mice were exposure to the local ambient particle (110,111). To investigate the relation between individual-level estimates of long-term air pollution exposure and the progression of subclinical atherosclerosis, a large prospective, multicenter study named Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) was initiated in 2004. That study demonstrated that long-term PM2.5 exposure was significantly associated with decreased endothelial function with increased IMT progression even over a relatively short follow-up period, which add to the literature on air pollution and the progression of atherosclerotic processes in humans (112,113). Even more, the authors observed that the slower IMT progression was related to greater reductions in PM2.5. A very recent study recalled the data [2000-2003] from the German Heinz Nixdorf Recall Study, which included a population-based cohort of 4,814 randomly selected participants. The study used a reliable indice, the thoracic aortic calcification (TAC), to evaluate the subclinical atherosclerosis. Their results demonstrated that long-term exposure to fine PM is independently associated with subclinical atherosclerosis (114). Taken together, these findings may elucidate important pathways linking air pollution to the development of atherosclerosis.

Thrombus formation, blood coagulation and particulate matter (PM) particulate exposure

In vivo as well as in vitro studies demonstrated that PM particulates can induce pro-thrombotic effects by producing inflammatory mediators in the lungs and releasing into the blood circulation or directly translocation of small particulates from lung to the circulation. Nemmar et al. revealed that exposure of hamster to the diesel exhaust particles after photochemical injury resulted in platelet function abnormalities and thrombus formation both in arteries and veins (115). Mutlu GM and his colleague using IL-6 knockout (KO) mouse model demonstrated that IL-6 and its downstream signaling pathway plays a pivotal role in PM-induced prothrombotic state by increasing the expression of fibrinogen, factor VIII and tissue factor (TF), thus increasing the risk of both venous and arterial thrombosis (34,116). Furthermore, they also found that the prothrombotic effect of PM was further mitigated in macrophage-depleted mice (116). Those results may suggest that IL-6, macrophage and pulmonary inflammation are the necessary initial steps for PM-induced prothrombotic changes. Kilinç et al. documented the possible mechanisms for early and chronic exposure of PM (UFPs)-driven procoagulant activity in genetically modified mice [FXII(−/−)]. They revealed that PM promotes its early procoagulant actions mostly through the TF-driven extrinsic pathway of coagulation, whereas PM-driven long lasting thrombogenic effects are predominantly mediated via formation of activated FXII. Hence, they concluded that FXII-driven thrombin formation may be relevant to an enhanced thrombotic susceptibility upon chronic exposure to PM in humans (40). In addition to increasing the inflammatory mediators and prothrombotic proteins, particulate nanoparticles and other UFPs themselves could reach the circulation and directly enhance thrombus formation as analyzed by scanning electron microscopes (117). In real-world studies, the MONICA survey indicated that plasma viscosity was increased in both men and women when exposure to air pollutions (118). Recently, researchers studied the effects of short-term changes in exposure to UFPs on stroke, separately for ischaemic and hemorrhagic strokes, and ischaemic strokes with (likely embolic) and without (likely thrombotic) AF. Their results demonstrated that exposure to UFPs lead to a 21% increase in hospital admissions (per interquartile range of 5-day averages; 95% CI: 4-41%) for mild ischaemic stroke of without AF (likely thrombotic origin), which may further indicate the thrombotic and procoagulant actions of PM particles (119).


Conclusions

In summary, a wide array of experimental and epidemiological studies have unequivocally provided persuasive evidences on the negative impact of PMs on cardiovascular events and outcomes. In addition, numerous findings indicate that even a few hours to weeks of short-term exposure to PM particulates can trigger CVD-related mortality and events, especially among the susceptible individuals at great risk including the elderly or the patients with preexisting coronary artery disease. The underlying mechanisms for PM-caused cardiovascular disease include directly insults by UFPs translocating to the circulations and remote localization to the heart or indirectly injury by inducing systemic inflammation and oxidative stress in circulation, thus leading to cardiovascular damage. However, even the epidemiology and the biomedical studies will possibly help us better understand the underlying mechanisms and increase the effectiveness of our efforts to reduce the risk of air pollution—related cardiovascular disease, the major strategy in decreasing the harmful effects of air pollution is to reduce the air pollutants themselves. As the air pollution is becoming an ecological and social dilemma in the world, especially in developing countries like China, the social movements backed up by medical doctors, medias and government, therefore, might be great needed to combat with the deteriorating air pollution problem and finally to lower the associated cardiovascular risk.


Acknowledgements

Funding: This work was supported by the National Natural Science Foundation of China (NSFC 30900602, J Wang) and National Natural Science Foundation of Jiangsu Province (BK2012879 to J Wang and BK2011382 to Y Guo); Dr. Wang was also supported by the “Sixth-Peak Talent” of Jiangsu Province (2013WSN-036).


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.


References

  1. Dockery DW, Pope CA 3rd, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753-9. [PubMed]
  2. Pope CA 3rd, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:1132-41. [PubMed]
  3. Simoni M, Baldacci S, Maio S, et al. Adverse effects of outdoor pollution in the elderly. J Thorac Dis 2015;7:34-45. [PubMed]
  4. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004;109:2655-71. [PubMed]
  5. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010;121:2331-78. [PubMed]
  6. Dockery DW, Stone PH. Cardiovascular risks from fine particulate air pollution. N Engl J Med 2007;356:511-3. [PubMed]
  7. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 2006;99:692-705. [PubMed]
  8. Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol 2008;52:719-26. [PubMed]
  9. Burch WM. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;106:e141-2; author reply e141-2.
  10. Li H, Chen R, Meng X, et al. Short-term exposure to ambient air pollution and coronary heart disease mortality in 8 Chinese cities. Int J Cardiol 2015;197:265-70. [PubMed]
  11. Wolf K, Schneider A, Breitner S, et al. Associations between short-term exposure to particulate matter and ultrafine particles and myocardial infarction in Augsburg, Germany. Int J Hyg Environ Health 2015;218:535-42. [PubMed]
  12. Powell H, Krall JR, Wang Y, et al. Ambient Coarse Particulate Matter and Hospital Admissions in the Medicare Cohort Air Pollution Study, 1999-2010. Environ Health Perspect 2015;123:1152-8. [PubMed]
  13. Faustini A, Alessandrini ER, Pey J, et al. Short-term effects of particulate matter on mortality during forest fires in Southern Europe: results of the MED-PARTICLES Project. Occup Environ Med 2015;72:323-9. [PubMed]
  14. Chang CC, Chen PS, Yang CY. Short-term effects of fine particulate air pollution on hospital admissions for cardiovascular diseases: a case-crossover study in a tropical city. J Toxicol Environ Health A 2015;78:267-77. [PubMed]
  15. Talbott EO, Rager JR, Benson S, et al. A case-crossover analysis of the impact of PM(2.5) on cardiovascular disease hospitalizations for selected CDC tracking states. Environ Res 2014;134:455-65. [PubMed]
  16. Bhaskaran K, Hajat S, Armstrong B, et al. The effects of hourly differences in air pollution on the risk of myocardial infarction: case crossover analysis of the MINAP database. BMJ 2011;343:d5531. [PubMed]
  17. Zhao A, Chen R, Kuang X, et al. Ambient air pollution and daily outpatient visits for cardiac arrhythmia in Shanghai, China. J Epidemiol 2014;24:321-6. [PubMed]
  18. Raza A, Bellander T, Bero-Bedada G, et al. Short-term effects of air pollution on out-of-hospital cardiac arrest in Stockholm. Eur Heart J 2014;35:861-8. [PubMed]
  19. Bell ML, Ebisu K, Leaderer BP, et al. Associations of PM2.5 constituents and sources with hospital admissions: analysis of four counties in Connecticut and Massachusetts (USA) for persons ≥ 65 years of age. Environ Health Perspect 2014;122:138-44. [PubMed]
  20. Hajat A, Allison M, Diez-Roux AV, et al. Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA). Epidemiology 2015;26:310-20. [PubMed]
  21. Qin XD, Qian Z, Vaughn MG, et al. Gender-specific differences of interaction between obesity and air pollution on stroke and cardiovascular diseases in Chinese adults from a high pollution range area: A large population based cross sectional study. Sci Total Environ 2015;529:243-8. [PubMed]
  22. Wolf K, Stafoggia M, Cesaroni G, et al. Long-term Exposure to Particulate Matter Constituents and the Incidence of Coronary Events in 11 European Cohorts. Epidemiology 2015;26:565-74. [PubMed]
  23. Wong CM, Lai HK, Tsang H, et al. Satellite-Based Estimates of Long-Term Exposure to Fine Particles and Association with Mortality in Elderly Hong Kong Residents. Environ Health Perspect 2015;123:1167-72. [PubMed]
  24. Chan SH, Van Hee VC, Bergen S, et al. Long-Term Air Pollution Exposure and Blood Pressure in the Sister Study. Environ Health Perspect 2015;123:951-8. [PubMed]
  25. Pope CA 3rd, Turner MC, Burnett RT, et al. Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality. Circ Res 2015;116:108-15. [PubMed]
  26. Kim SY, Sheppard L, Kaufman JD, et al. Individual-level concentrations of fine particulate matter chemical components and subclinical atherosclerosis: a cross-sectional analysis based on 2 advanced exposure prediction models in the multi-ethnic study of atherosclerosis. Am J Epidemiol 2014;180:718-28. [PubMed]
  27. Wilker EH, Ljungman PL, Rice MB, et al. Relation of long-term exposure to air pollution to brachial artery flow-mediated dilation and reactive hyperemia. Am J Cardiol 2014;113:2057-63. [PubMed]
  28. Weichenthal S, Villeneuve PJ, Burnett RT, et al. Long-term exposure to fine particulate matter: association with nonaccidental and cardiovascular mortality in the agricultural health study cohort. Environ Health Perspect 2014;122:609-15. [PubMed]
  29. Beelen R, Stafoggia M, Raaschou-Nielsen O, et al. Long-term exposure to air pollution and cardiovascular mortality: an analysis of 22 European cohorts. Epidemiology 2014;25:368-78. [PubMed]
  30. Zhou M, Liu Y, Wang L, et al. Particulate air pollution and mortality in a cohort of Chinese men. Environ Pollut 2014;186:1-6. [PubMed]
  31. Chen H, Goldberg MS, Burnett RT, et al. Long-term exposure to traffic-related air pollution and cardiovascular mortality. Epidemiology 2013;24:35-43. [PubMed]
  32. Pope CA 3rd, Burnett RT, Thurston GD, et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004;109:71-7. [PubMed]
  33. Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007;356:447-58. [PubMed]
  34. Shrey K, Suchit A, Deepika D, et al. Air pollutants: the key stages in the pathway towards the development of cardiovascular disorders. Environ Toxicol Pharmacol 2011;31:1-9. [PubMed]
  35. Nemmar A, Hoet PH, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;105:411-4. [PubMed]
  36. Furuyama A, Kanno S, Kobayashi T, et al. Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch Toxicol 2009;83:429-37. [PubMed]
  37. Oberdörster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002;65:1531-43. [PubMed]
  38. Chen J, Tan M, Nemmar A, et al. Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 2006;222:195-201. [PubMed]
  39. He X, Zhang H, Ma Y, et al. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology 2010;21:285103. [PubMed]
  40. Kilinç E, Van Oerle R, Borissoff JI, et al. Factor XII activation is essential to sustain the procoagulant effects of particulate matter. J Thromb Haemost 2011;9:1359-67. [PubMed]
  41. Wold LE, Simkhovich BZ, Kleinman MT, et al. In vivo and in vitro models to test the hypothesis of particle-induced effects on cardiac function and arrhythmias. Cardiovasc Toxicol 2006;6:69-78. [PubMed]
  42. Simkhovich BZ, Marjoram P, Kleinman MT, et al. Direct and acute cardiotoxicity of ultrafine particles in young adult and old rat hearts. Basic Res Cardiol 2007;102:467-75. [PubMed]
  43. Huang W, Wang G, Lu SE, et al. Inflammatory and oxidative stress responses of healthy young adults to changes in air quality during the Beijing Olympics. Am J Respir Crit Care Med 2012;186:1150-9. [PubMed]
  44. Seagrave J. Mechanisms and implications of air pollution particle associations with chemokines. Toxicol Appl Pharmacol 2008;232:469-77. [PubMed]
  45. Ghio AJ, Devlin RB. Inflammatory lung injury after bronchial instillation of air pollution particles. Am J Respir Crit Care Med 2001;164:704-8. [PubMed]
  46. Meier R, Cascio WE, Ghio AJ, et al. Associations of short-term particle and noise exposures with markers of cardiovascular and respiratory health among highway maintenance workers. Environ Health Perspect 2014;122:726-32. [PubMed]
  47. Gurgueira SA, Lawrence J, Coull B, et al. Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation. Environ Health Perspect 2002;110:749-55. [PubMed]
  48. Steinvil A, Kordova-Biezuner L, Shapira I, et al. Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res 2008;106:51-61. [PubMed]
  49. van Eeden SF, Tan WC, Suwa T, et al. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med 2001;164:826-30. [PubMed]
  50. Wang J, Tang B, Liu X, et al. Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease. Atherosclerosis 2015;239:343-9. [PubMed]
  51. Astort F, Sittner M, Ferraro SA, et al. Pulmonary inflammation and cell death in mice after acute exposure to air particulate matter from an industrial region of Buenos Aires. Arch Environ Contam Toxicol 2014;67:87-96. [PubMed]
  52. Sijan Z, Antkiewicz DS, Heo J, et al. An in vitro alveolar macrophage assay for the assessment of inflammatory cytokine expression induced by atmospheric particulate matter. Environ Toxicol 2015;30:836-51. [PubMed]
  53. Ying Z, Kampfrath T, Thurston G, et al. Ambient particulates alter vascular function through induction of reactive oxygen and nitrogen species. Toxicol Sci 2009;111:80-8. [PubMed]
  54. Schriewer JM, Peek CB, Bass J, et al. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J Am Heart Assoc 2013;2:e000159. [PubMed]
  55. Magari SR, Schwartz J, Williams PL, et al. The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology 2002;13:305-10. [PubMed]
  56. Martinelli N, Olivieri O, Girelli D. Air particulate matter and cardiovascular disease: a narrative review. Eur J Intern Med 2013;24:295-302. [PubMed]
  57. Bollati V, Iodice S, Favero C, et al. Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study. BMC Public Health 2014;14:1137. [PubMed]
  58. Fossati S, Baccarelli A, Zanobetti A, et al. Ambient particulate air pollution and microRNAs in elderly men. Epidemiology 2014;25:68-78. [PubMed]
  59. Wilker EH, Alexeeff SE, Suh H, et al. Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study. Environ Health 2011;10:45. [PubMed]
  60. Pope CA 3rd, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc 2006;56:709-42. [PubMed]
  61. Roberts S, Martin MA. Applying a moving total mortality count to the cities in the NMMAPS database to estimate the mortality effects of particulate matter air pollution. Occup Environ Med 2006;63:193-7. [PubMed]
  62. Stylianou M, Nicolich MJ. Cumulative effects and threshold levels in air pollution mortality: data analysis of nine large US cities using the NMMAPS dataset. Environ Pollut 2009;157:2216-23. [PubMed]
  63. Samoli E, Analitis A, Touloumi G, et al. Estimating the exposure-response relationships between particulate matter and mortality within the APHEA multicity project. Environ Health Perspect 2005;113:88-95. [PubMed]
  64. Samoli E, Touloumi G, Zanobetti A, et al. Investigating the dose-response relation between air pollution and total mortality in the APHEA-2 multicity project. Occup Environ Med 2003;60:977-82. [PubMed]
  65. Qian Z, He Q, Lin HM, et al. High temperatures enhanced acute mortality effects of ambient particle pollution in the "oven" city of Wuhan, China. Environ Health Perspect 2008;116:1172-8. [PubMed]
  66. Banerjee M, Siddique S, Mukherjee S, et al. Hematological, immunological, and cardiovascular changes in individuals residing in a polluted city of India: a study in Delhi. Int J Hyg Environ Health 2012;215:306-11. [PubMed]
  67. Tsai FC, Smith KR, Vichit-Vadakan N, et al. Indoor/outdoor PM10 and PM2.5 in Bangkok, Thailand. J Expo Anal Environ Epidemiol 2000;10:15-26. [PubMed]
  68. Atkinson RW, Carey IM, Kent AJ, et al. Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases. Epidemiology 2013;24:44-53. [PubMed]
  69. Mustafic H, Jabre P, Caussin C, et al. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA 2012;307:713-21. [PubMed]
  70. Laden F, Schwartz J, Speizer FE, et al. Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med 2006;173:667-72. [PubMed]
  71. Boldo E, Linares C, Lumbreras J, et al. Health impact assessment of a reduction in ambient PM(2.5) levels in Spain. Environ Int 2011;37:342-8. [PubMed]
  72. Poloniecki JD, Atkinson RW, de Leon AP, et al. Daily time series for cardiovascular hospital admissions and previous day's air pollution in London, UK. Occup Environ Med 1997;54:535-40. [PubMed]
  73. Dominici F, Peng RD, Bell ML, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 2006;295:1127-34. [PubMed]
  74. von Klot S, Peters A, Aalto P, et al. Ambient air pollution is associated with increased risk of hospital cardiac readmissions of myocardial infarction survivors in five European cities. Circulation 2005;112:3073-9. [PubMed]
  75. Cesaroni G, Forastiere F, Stafoggia M, et al. Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ 2014;348:f7412. [PubMed]
  76. Lipsett MJ, Ostro BD, Reynolds P, et al. Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med 2011;184:828-35. [PubMed]
  77. von Klot S, Cyrys J, Hoek G, et al. Estimated personal soot exposure is associated with acute myocardial infarction onset in a case-crossover study. Prog Cardiovasc Dis 2011;53:361-8. [PubMed]
  78. Sullivan J, Sheppard L, Schreuder A, et al. Relation between short-term fine-particulate matter exposure and onset of myocardial infarction. Epidemiology 2005;16:41-8. [PubMed]
  79. Wiebert P, Lönn M, Fremling K, et al. Occupational exposure to particles and incidence of acute myocardial infarction and other ischaemic heart disease. Occup Environ Med 2012;69:651-7. [PubMed]
  80. Cozzi E, Hazarika S, Stallings HW 3rd, et al. Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2006;291:H894-903. [PubMed]
  81. Wellenius GA, Coull BA, Godleski JJ, et al. Inhalation of concentrated ambient air particles exacerbates myocardial ischemia in conscious dogs. Environ Health Perspect 2003;111:402-8. [PubMed]
  82. Bartoli CR, Wellenius GA, Coull BA, et al. Concentrated ambient particles alter myocardial blood flow during acute ischemia in conscious canines. Environ Health Perspect 2009;117:333-7. [PubMed]
  83. Nemmar A, Hoylaerts MF, Nemery B. Effects of particulate air pollution on hemostasis. Clin Occup Environ Med 2006;5:865-81. [PubMed]
  84. Dockery DW, Luttmann-Gibson H, Rich DQ, et al. Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators. Environ Health Perspect 2005;113:670-4. [PubMed]
  85. Peters A, Liu E, Verrier RL, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000;11:11-7. [PubMed]
  86. Chiu HF, Tsai SS, Weng HH, et al. Short-term effects of fine particulate air pollution on emergency room visits for cardiac arrhythmias: a case-crossover study in Taipei. J Toxicol Environ Health A 2013;76:614-23. [PubMed]
  87. Link MS, Luttmann-Gibson H, Schwartz J, et al. Acute exposure to air pollution triggers atrial fibrillation. J Am Coll Cardiol 2013;62:816-25. [PubMed]
  88. Straney L, Finn J, Dennekamp M, et al. Evaluating the impact of air pollution on the incidence of out-of-hospital cardiac arrest in the Perth Metropolitan Region: 2000-2010. J Epidemiol Community Health 2014;68:6-12. [PubMed]
  89. Ensor KB, Raun LH, Persse D. A case-crossover analysis of out-of-hospital cardiac arrest and air pollution. Circulation 2013;127:1192-9. [PubMed]
  90. Silverman RA, Ito K, Freese J, et al. Association of ambient fine particles with out-of-hospital cardiac arrests in New York City. Am J Epidemiol 2010;172:917-23. [PubMed]
  91. Wichmann J, Folke F, Torp-Pedersen C, et al. Out-of-hospital cardiac arrests and outdoor air pollution exposure in Copenhagen, Denmark. PLoS One 2013;8:e53684. [PubMed]
  92. Levy D, Sheppard L, Checkoway H, et al. A case-crossover analysis of particulate matter air pollution and out-of-hospital primary cardiac arrest. Epidemiology 2001;12:193-9. [PubMed]
  93. Huikuri HV, Exner DV, Kavanagh KM, et al. Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events. Heart Rhythm 2010;7:229-35. [PubMed]
  94. Piotrowicz E, Baranowski R, Piotrowska M, et al. Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure. Pacing Clin Electrophysiol 2009;32 Suppl 1:S113-5. [PubMed]
  95. Huang YL, Chen HW, Han BC, et al. Personal exposure to household particulate matter, household activities and heart rate variability among housewives. PLoS One 2014;9:e89969. [PubMed]
  96. Bortkiewicz A, Gadzicka E, Stroszejn-Mrowca G, et al. Cardiovascular changes in workers exposed to fine particulate dust. Int J Occup Med Environ Health 2014;27:78-92. [PubMed]
  97. Bartell SM, Longhurst J, Tjoa T, et al. Particulate air pollution, ambulatory heart rate variability, and cardiac arrhythmia in retirement community residents with coronary artery disease. Environ Health Perspect 2013;121:1135-41. [PubMed]
  98. Langrish JP, Mills NL, Chan JK, et al. Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol 2009;6:8. [PubMed]
  99. Langrish JP, Li X, Wang S, et al. Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect 2012;120:367-72. [PubMed]
  100. Ghelfi E, Rhoden CR, Wellenius GA, et al. Cardiac oxidative stress and electrophysiological changes in rats exposed to concentrated ambient particles are mediated by TRP-dependent pulmonary reflexes. Toxicol Sci 2008;102:328-36. [PubMed]
  101. Ren C, Baccarelli A, Wilker E, et al. Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability--the VA Normative Aging Study. J Epidemiol Community Health 2010;64:49-56. [PubMed]
  102. Probst-Hensch NM, Imboden M, Felber Dietrich D, et al. Glutathione S-transferase polymorphisms, passive smoking, obesity, and heart rate variability in nonsmokers. Environ Health Perspect 2008;116:1494-9. [PubMed]
  103. Courtois A, Prouillac C, Baudrimont I, et al. Characterization of the components of urban particulate matter mediating impairment of nitric oxide-dependent relaxation in intrapulmonary arteries. J Appl Toxicol 2014;34:667-74. [PubMed]
  104. Calderón-Garcidueñas L, Villarreal-Calderon R, Valencia-Salazar G, et al. Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. Inhal Toxicol 2008;20:499-506. [PubMed]
  105. Lund AK, Lucero J, Lucas S, et al. Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways. Arterioscler Thromb Vasc Biol 2009;29:511-7. [PubMed]
  106. Urch B, Silverman F, Corey P, et al. Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect 2005;113:1052-5. [PubMed]
  107. Mills NL, Törnqvist H, Robinson SD, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 2005;112:3930-6. [PubMed]
  108. Perez L, Wolf K, Hennig F, et al. Air pollution and atherosclerosis: a cross-sectional analysis of four European cohort studies in the ESCAPE study. Environ Health Perspect 2015;123:597-605. [PubMed]
  109. Sun Q, Wang A, Jin X, et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 2005;294:3003-10. [PubMed]
  110. Chen T, Jia G, Wei Y, et al. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice. Toxicol Lett 2013;223:146-53. [PubMed]
  111. Araujo JA, Barajas B, Kleinman M, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res 2008;102:589-96. [PubMed]
  112. Krishnan RM, Adar SD, Szpiro AA, et al. Vascular responses to long- and short-term exposure to fine particulate matter: MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution). J Am Coll Cardiol 2012;60:2158-66. [PubMed]
  113. Adar SD, Sheppard L, Vedal S, et al. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PLoS Med 2013;10:e1001430. [PubMed]
  114. Kälsch H, Hennig F, Moebus S, et al. Are air pollution and traffic noise independently associated with atherosclerosis: the Heinz Nixdorf Recall Study. Eur Heart J 2014;35:853-60. [PubMed]
  115. Nemmar A, Hoet PH, Dinsdale D, et al. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 2003;107:1202-8. [PubMed]
  116. Mutlu GM, Green D, Bellmeyer A, et al. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest 2007;117:2952-61. [PubMed]
  117. Silva VM, Corson N, Elder A, et al. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci 2005;85:983-9. [PubMed]
  118. Peters A, Döring A, Wichmann HE, et al. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997;349:1582-7. [PubMed]
  119. Andersen ZJ, Olsen TS, Andersen KK, et al. Association between short-term exposure to ultrafine particles and hospital admissions for stroke in Copenhagen, Denmark. Eur Heart J 2010;31:2034-40. [PubMed]
Cite this article as: Du Y, Xu X, Chu M, Guo Y, Wang J. Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence. J Thorac Dis 2016;8(1):E8-E19. doi: 10.3978/j.issn.2072-1439.2015.11.37